Li Wenkui, Tse Francis L S
Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, NJ 07936, USA.
Biomed Chromatogr. 2010 Jan;24(1):49-65. doi: 10.1002/bmc.1367.
The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS-LC-MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS-LC-MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS-LS-MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS-LC-MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage.
在纸上采集全血样本,即所谓的干血斑(DBS),可追溯到20世纪60年代初用于遗传性代谢疾病的新生儿筛查。与传统采血相比,DBS具有许多优势。作为一种侵入性较小的采样方法,DBS的样本采集和储存更简单,转移更容易,各种病原体的感染风险降低,且所需血量较少。迄今为止,DBS-液相色谱-串联质谱法(DBS-LC-MS/MS)已成为小分子定量分析的重要方法。尽管DBS-LC-MS/MS越来越受欢迎,但由于样本量小,该方法在检测灵敏度方面存在局限性。样本质量往往是一个问题。有必要对各种血液样本特性对目标分析物准确定量的潜在影响进行系统评估。虽然大多数分析物在DBS上可能是稳定的,但不稳定化合物给DBS带来了另一个挑战,因为在样本采集过程中无法方便地混合酶抑制剂。需要改进DBS卡的化学性能。除了介绍许多具有代表性的DBS-LS-MS/MS应用外,本综述还重点介绍了开发和验证一种用于小分子定量分析的稳健的DBS-LC-MS/MS方法的一些重要方面,以及DBS样本的采集、处理和储存。